John Morici, the EVP of $ALGN, sold 7,969 shares of the company on 02-18-2026 for an estimated $1,508,645. We received data on the trade from a recent SEC filing. This was a sale of approximately 49.2% of their shares of this class of stock. Following this trade, they now own 8,237 shares of this class of $ALGN stock.
$ALGN Insider Trading Activity
$ALGN insiders have traded $ALGN stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ALGN stock by insiders over the last 6 months:
- JOHN MORICI (EVP, CHIEF FINANCIAL OFFICER) sold 7,969 shares for an estimated $1,508,645
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ALGN Hedge Fund Activity
We have seen 328 institutional investors add shares of $ALGN stock to their portfolio, and 460 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,104,365 shares (-81.9%) from their portfolio in Q4 2025, for an estimated $328,596,594
- WELLINGTON MANAGEMENT GROUP LLP removed 1,773,839 shares (-95.9%) from their portfolio in Q4 2025, for an estimated $276,984,959
- CAPITAL INTERNATIONAL INVESTORS added 1,592,848 shares (+52.2%) to their portfolio in Q4 2025, for an estimated $248,723,215
- HOLOCENE ADVISORS, LP removed 1,429,761 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $223,257,180
- RUANE, CUNNIFF & GOLDFARB L.P. added 1,222,534 shares (+inf%) to their portfolio in Q4 2025, for an estimated $190,898,684
- FMR LLC added 1,154,694 shares (+136.7%) to their portfolio in Q4 2025, for an estimated $180,305,468
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,059,026 shares (-46.9%) from their portfolio in Q4 2025, for an estimated $165,366,909
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ALGN Revenue
$ALGN had revenues of $1B in Q4 2025. This is an increase of 5.26% from the same period in the prior year.
You can track ALGN financials on Quiver Quantitative's ALGN stock page.
$ALGN Congressional Stock Trading
Members of Congress have traded $ALGN stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ALGN stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ALGN Analyst Ratings
Wall Street analysts have issued reports on $ALGN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 01/20/2026
- Wells Fargo issued a "Overweight" rating on 10/30/2025
- Piper Sandler issued a "Overweight" rating on 10/30/2025
- Evercore ISI Group issued a "Outperform" rating on 10/30/2025
To track analyst ratings and price targets for $ALGN, check out Quiver Quantitative's $ALGN forecast page.
$ALGN Price Targets
Multiple analysts have issued price targets for $ALGN recently. We have seen 10 analysts offer price targets for $ALGN in the last 6 months, with a median target of $200.0.
Here are some recent targets:
- Sidharth Sahoo from HSBC set a target price of $200.0 on 02/09/2026
- Kevin Caliendo from UBS set a target price of $185.0 on 02/05/2026
- Erin Wright from Morgan Stanley set a target price of $169.0 on 02/05/2026
- Jason Bednar from Piper Sandler set a target price of $220.0 on 02/05/2026
- Vik Chopra from Wells Fargo set a target price of $200.0 on 02/05/2026
- Jonathan Block from Stifel set a target price of $210.0 on 02/05/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $200.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
